2005
DOI: 10.1016/j.expneurol.2005.08.011
|View full text |Cite
|
Sign up to set email alerts
|

Dose-dependent beneficial and detrimental effects of ROCK inhibitor Y27632 on axonal sprouting and functional recovery after rat spinal cord injury

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

4
103
1
5

Year Published

2006
2006
2018
2018

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 129 publications
(113 citation statements)
references
References 54 publications
4
103
1
5
Order By: Relevance
“…HA1077 is in clinical use for managing cerebral vasospasm associated with subarachnoid hemorrhage and is under clinical trial for acute ischemic stroke [37], among other conditions. Application of Y27632 has also been investigated for promotion of neurite outgrowth and axonal regeneration [38][39][40][41][42][43][44][45] and inactivation of Rho or ROCK signaling promoted functional recovery and/or axonal regeneration after neural injuries [46][47][48].…”
Section: Introductionmentioning
confidence: 99%
“…HA1077 is in clinical use for managing cerebral vasospasm associated with subarachnoid hemorrhage and is under clinical trial for acute ischemic stroke [37], among other conditions. Application of Y27632 has also been investigated for promotion of neurite outgrowth and axonal regeneration [38][39][40][41][42][43][44][45] and inactivation of Rho or ROCK signaling promoted functional recovery and/or axonal regeneration after neural injuries [46][47][48].…”
Section: Introductionmentioning
confidence: 99%
“…If translated into the human setting, these beneficial effects would greatly exceed the expected risks. Other molecules targeting the Rho pathway have also been shown to promote recovery from rodent CNS injury, including variants of the C3 exoenzyme that inactivates RhoA, and compounds that block a downstream signaling molecule, ROCK (Chan et al, 2005;Dergham et al, 2002;Fournier et al, 2003;McKerracher and Higuchi, 2006). Compounds related to ibuprofen might provide a useful starting point to screen for optimal Rho pathway inhibition and future SCI or stroke recovery therapeutics.…”
Section: ‰ Ibuprofen In Spinal Cord Injury 91mentioning
confidence: 99%
“…Downstream of RhoA, Rhoassociated kinase (ROCK) mediates, in part, the actions of RhoA (Borisoff et al, 2003;Chan et al, 2005;Fournier et al, 2003;Monnier et al, 2003;Nakagawa et al, 1996). ROCK inhibitors promote axonal growth in vitro, and improve behavioral recovery from spinal injury at certain doses when administered shortly after injury (Borisoff et al, 2003;Chan et al, 2005;Dergham et al, 2002;Fournier et al, 2003; Program in Cellular Neuroscience, Neurodegeneration, and Repair, Yale University School of Medicine, New Haven, Connecticut.…”
mentioning
confidence: 99%
“…Fournier et al [26] report that C3 transferase has no effect on sprouting. Lastly, there were two studies that demonstrate axonal regeneration [12,20] and a single study that showed no effect on regeneration of injured axons [26]. Seven of nine studies reported on behavioral outcomes.…”
Section: Questionmentioning
confidence: 99%
“…This compound is directly applied to the dura at the time of surgery after injury. In our systematic review we identified nine preclinical studies that examined the effect of Rho antagonists in the setting of SCI [12,20,24,26,38,46,57,58,63]. These investigations made use of a combination of mouse and rat models consisting of dorsal hemisection, impactor injury, transection, and hemisection ( [63].…”
Section: Questionmentioning
confidence: 99%